title: Higher medication doses in heart failure?
authors.affiliation: Professor in the Faculty of Pharmaceutical Sciences at the University of British Columbia in Vancouver.
authors.forename: James
authors.initials: J
authors.lastname: McCormack
authors.affiliation: Professor in the Faculty of Medicine and Dentistry at the University of Alberta in Edmonton.
authors.forename: Finlay A
authors.initials: FA
authors.lastname: McAlister
authors.affiliation: Associate Professor in the Faculty of Medicine and Dentistry at the University of Alberta in Edmonton.
authors.forename: Michael R
authors.initials: MR
authors.lastname: Kolber
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D057911:Angiotensin Receptor Antagonists / Q000008:administration & dosage* / Q000009:adverse effects; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D016903:Drug Monitoring
chemical_list: D000319:Adrenergic beta-Antagonists; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors